Bacteriophages and phage tail-like bacteriocins (PTLBs) rely on receptor-binding proteins (RBPs) located in tail fibers or spikes for an initial and specific interaction with susceptible bacteria. Bacteriophages kill bacteria through a lytic, replicative cycle, whereas PTLBs kill the target through membrane depolarization in a single hit mechanism. Extensive efforts in the engineering of RBPs of both phages and PTLBs have been undertaken to obtain a greater understanding of the structural organization of RBPs. In addition, a major goal of engineering RBPs of phages and PTLBs is the production of antibacterials with a customized spectrum. Swapping of the RBP of phages and PTLBs results in a shift in activity spectrum in accordance with the s...
Klebsiella pneumoniae carries a thick and diverse polysaccharide capsule that plays an important rol...
The antimicrobial and therapeutic efficacy of bacteriophages is currently limited, mostly due to rap...
Pseudomonads are equipped with an arsenal of antagonism-mediating compounds to harness themselves in...
Bacteriophages and phage tail-like bacteriocins (PTLBs) rely on receptor-binding proteins (RBPs) loc...
Phage Tail Like bacteriocins (PTLBs) has been an area of interest in the last couple of years owing ...
The antimicrobial resistance crisis has rekindled interest in bacteriophage therapy. Phages have bee...
Next to pandemics and wars, antibiotic resistance is a drastically increasing problem the world must...
Phages differ substantially in the bacterial hosts that they infect. Their host range is determined ...
Recently, a large number of new technologies have been developed that exploit the unique properties ...
The first step in bacteriophage infection is recognition and binding to the host receptor, which is ...
The increasing threat of antibiotic resistance calls for the development of new treatment methods. B...
The first step in bacteriophage infection is recognition and binding to the host receptor, which is ...
Despite the successful use of antibacterials, the emergence of multidrug-resistant bacteria has beco...
Klebsiella pneumoniae carries a thick and diverse polysaccharide capsule that plays an important rol...
The antimicrobial and therapeutic efficacy of bacteriophages is currently limited, mostly due to rap...
Pseudomonads are equipped with an arsenal of antagonism-mediating compounds to harness themselves in...
Bacteriophages and phage tail-like bacteriocins (PTLBs) rely on receptor-binding proteins (RBPs) loc...
Phage Tail Like bacteriocins (PTLBs) has been an area of interest in the last couple of years owing ...
The antimicrobial resistance crisis has rekindled interest in bacteriophage therapy. Phages have bee...
Next to pandemics and wars, antibiotic resistance is a drastically increasing problem the world must...
Phages differ substantially in the bacterial hosts that they infect. Their host range is determined ...
Recently, a large number of new technologies have been developed that exploit the unique properties ...
The first step in bacteriophage infection is recognition and binding to the host receptor, which is ...
The increasing threat of antibiotic resistance calls for the development of new treatment methods. B...
The first step in bacteriophage infection is recognition and binding to the host receptor, which is ...
Despite the successful use of antibacterials, the emergence of multidrug-resistant bacteria has beco...
Klebsiella pneumoniae carries a thick and diverse polysaccharide capsule that plays an important rol...
The antimicrobial and therapeutic efficacy of bacteriophages is currently limited, mostly due to rap...
Pseudomonads are equipped with an arsenal of antagonism-mediating compounds to harness themselves in...